Deborah C. Molrine, MD MPH (she/her/hers)

Clinical Program Director
CSL
Waltham, Massachusetts, United States

Presentation(s):

• A Randomized Study to Evaluate the Efficacy of a Cell-Based Quadrivalent Influenza Vaccine Compared to a Non-Influenza Vaccine in Children 6 Months to 47 Months of Age

  Sunday, April 27, 2025
  11:15am – 11:30am HST

  Disclosure(s): CSL Seqirus (Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)